Vireo Growth Inc. (VREOF): Depreciation & Amortization
$16.11M
Year ended 2025-12-31
+69.0%
3-year compound annual growth
+45.4%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.11M | +535.0% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $2.54M | -11.7% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $2.87M | -13.8% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | $3.34M | +10.1% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $3.03M | +22.1% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $2.48M | n/a | 2022-03-15, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $1.31M | +7.0% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $10.00M | 0.0% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $1.10M | -8.3% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $7.51M | +41.7% |
Compare VREOF, LGND, HROW, ARVN side by side · Screen every company in Pharmaceutical Preparations ↗